SEC Comment Letter for ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052) (AVXL) — Jun 9, 2017
ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052)
Date: June 9, 2017 · CIK: 0001314052 · Accession: 0000000000-17-020197
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-218292
Letter
Mail Stop 3561 June 9, 2017 Via E -mail Christopher Missling, PhD Chief Executive Officer Anavex Life Sciences Corp. 51 West 52nd Street, 7th Floor New York, NY 10019 -6163
Re: Anavex Life Sciences Corp. Registration Statement on Form S-3 Filed May 26, 2017 File No. 333-218292
Dear Dr. Missling :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Hillary Daniels at (202) 551 -3959 with any questions.
Sincerely,
/s/ Pamela Howell
for
Show Raw Text
Mail Stop 3561 June 9, 2017 Via E -mail Christopher Missling, PhD Chief Executive Officer Anavex Life Sciences Corp. 51 West 52nd Street, 7th Floor New York, NY 10019 -6163 Re: Anavex Life Sciences Corp. Registration Statement on Form S-3 Filed May 26, 2017 File No. 333-218292 Dear Dr. Missling : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Hillary Daniels at (202) 551 -3959 with any questions. Sincerely, /s/ Pamela Howell for John Reynolds Assistant Director Office of Beverages, Apparel, and Mining cc: Clayton E. Parker, Esq. K&L Gates LLP